Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... CLI in India including the prevalence of major risk factors; tobacco use, hypertension, dyslipidemia and diabetes in the Indian population. The number of people with PAD, TAO and CLI is ...
2009 NOV 23 ... of the company in May 2008. ETC-1002 is being developed to treat dyslipidemia, an early-stage risk factor of coronary artery disease and associated metabolic ...
2009 NOV 23 ... a case with the triad of splenomegaly with sea-blue histiocytes, nephropathy, and dyslipidemia in a patient with LCAT deficiency." Naghashpour and colleagues published ...
2009 NOV 24 ... need to take a proactive approach to managing their health," said Darryl Sleep, M.D., Dyslipidemia project director, Abbott. "These new Web sites encourage education, a healthy lifestyle ...
2009 NOV 23 ... have been associated with increased cardiovascular risk including glucose intolerance, dyslipidemia, and hypertension independent of one another. Weight loss is known to improve both ...
2009 NOV 23 ... that 3-wk VA supplementation has a triglyceride (TG)-lowering effect in a rat model of dyslipidemia, obesity, and metabolic syndrome (JCR:LA-cp rats)," scientists in Edmonton, Canada ...
2009 NOV 16 ... shrinkage (by median 80%), and improvement of hypertension, cardiac performance; and dyslipidemia. No patient was withdrawn from treatment because of side effects, and glucose tolerance ...
2009 NOV 23 ... protein tyrosine phosphatase, has previously been associated to glycemia, dyslipidemia, and obesity. In this study, ACP1 genotype and activity were tested in 3 18 women aged ...
2009 NOV 23 ... however, this mechanism is not the only factor that produces neuropathy in vivo. Dyslipidemia also correlates with the development of neuropathy, even in prediabetic patients. This ...
2009 NOV 16 ... at least in part to accelerated atherosclerosis and kidney injury associated with dyslipidemia and diabetes in mice. (Arterioscler Thromb Vasc Biol. 2009; 29:1779-1786.)." ...
2009 NOV 23 ... +/- 13 years) were either overweight (4) or obese (3); 57% were diabetic and 28.5% had dyslipidemia. Cirrhosis was present in 6 of 7 patients, but 1 patient had well-differentiated HCC in ...
2009 NOV 23 ... incidence of cardiovascular disease (CVD) risk factors such as hypertension and dyslipidemia. Both type 2 diabetes and obesity are independent risk factors for CVD," researchers in ...
2009 NOV 23 ... Mulvihill and colleagues published their study in Diabetes (Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor-Null Mice With ...
2009 NOV 16 ... < 0.001). Significant improvement in status was found for hypertension (P = 0.007), dyslipidemia (P = 0.002), and asthma (P = 0.011). Significant improvement was seen for aspirin use ...
2009 NOV 16 ... LDL and HDL affect function or survival of beta-cells and raise the question whether dyslipidemia contributes to beta-cell failure and hence the manifestation and progression of type 2 ...
2009 NOV 23 ... and colleagues. The researchers concluded: "Instead, visceral obesity and dyslipidemia components of the metabolic syndrome, i.e. hypertriglyceridemia and low HDL cholesterol ...
2009 NOV 23 ... of amlodipine/atorvastatin single pill in 494 African Americans with hypertension and dyslipidemia, according to the presence of diabetes +/- the metabolic syndrome." "In ...
2009 NOV 16 ... ligands of TLR2 or TLR4, thereby promoting diseases associated with inflammation and dyslipidemia, including atherosclerosis and insulin resistance." "We investigated the ...
2009 NOV 16 ... of Fibricor™ (fenofibric acid) for the treatment of primary hyperlipidemia, mixed dyslipidemia and severe hypertriglyceridemia. The U.S. Food and Drug Administration (FDA) granted ...
